Last reviewed · How we verify
Intradialytic parenteral nutrition
Intradialytic parenteral nutrition (IDPN) delivers intravenous amino acids, dextrose, and lipids directly into the bloodstream during hemodialysis sessions to supplement nutritional intake in malnourished dialysis patients.
Intradialytic parenteral nutrition (IDPN) delivers intravenous amino acids, dextrose, and lipids directly into the bloodstream during hemodialysis sessions to supplement nutritional intake in malnourished dialysis patients. Used for Protein-energy malnutrition in hemodialysis patients, Nutritional supplementation in end-stage renal disease patients unable to meet nutritional requirements orally.
At a glance
| Generic name | Intradialytic parenteral nutrition |
|---|---|
| Sponsor | EZUS-LYON 1 |
| Drug class | Nutritional supplement / parenteral nutrition formulation |
| Modality | Small molecule |
| Therapeutic area | Nephrology / Renal disease |
| Phase | FDA-approved |
Mechanism of action
IDPN is administered through the venous line of the dialysis circuit during treatment, allowing simultaneous delivery of macronutrients while waste removal occurs. This approach bypasses the gastrointestinal tract and provides concentrated nutrition to patients with inadequate oral intake or protein-energy wasting, a common complication of end-stage renal disease. The timing during dialysis optimizes nutrient delivery while minimizing additional vascular access requirements.
Approved indications
- Protein-energy wasting in hemodialysis patients with inadequate oral nutritional intake
- Malnutrition in end-stage renal disease patients undergoing maintenance hemodialysis
Common side effects
- Hyperglycemia
- Hypertriglyceridemia
- Vascular access complications
- Infection at access site
- Electrolyte imbalances
Key clinical trials
- The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients (PHASE4)
- Long-term Muscle Synthetic Effects of Intradialytic Parenteral Nutrition in Chronic Hemodialysis Patients (NA)
- Ketoacid Analogues Intradialytic Effect on Inflammation (NA)
- Impact of IDPN on Nutrition Markers in Patients Receiving ICHD
- Study of 2 Modalities of Dialysis and Nutrition on the Nutritional Status of Malnourished Chronic Renal Disease Patients (NA)
- Incomes of Nutritional Support Modalities in Hemodialysis Patients With Severe Malnutrition
- Intradialytic Parenteral Nutrition in Hemodialysis Patients (PHASE4)
- Effect of Intradialytic Physical ACTIvity in Addition to a NUTritional Support on Protein Energy Wasting and Physical Functioning in Chronic Hemodialysis Patients ("ACTINUT" Study) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intradialytic parenteral nutrition CI brief — competitive landscape report
- Intradialytic parenteral nutrition updates RSS · CI watch RSS
- EZUS-LYON 1 portfolio CI